CIME 2025: Luke Lindsell, OD, MD, on bridging innovation and practical care in retinal disease
May 8th 2025Lindsell discusses promising retinal therapeutics, such as at-home therapies, gene therapy, and devices like the Valeda Light Delivery System (LumiThera), which uses photobiomodulation and shows early promise in preventing geographic atrophy altogether.
ARVO 2025: Exploring a conversion factor between 2 OCT devices to monitor glaucoma progression
Hammond and his team focused on creating a reliable conversion factor between 2 widely used optical coherence tomography (OCT) systems—the TopCon Maestro2 and the ZEISS Cirrus 5000. Their work specifically looked at ganglion cell–inner plexiform layer and retinal nerve fiber layer thickness measurements, which are critical markers in glaucoma diagnosis and monitoring.
ASCRS 2025: Recognizing and managing neurotrophic keratitis with cryopreserved amniotic membrane
An emerging treatment approach for a commonly underdiagnosed ocular surface disease.
ASCRS 2025: Enhancing patient outcomes with presbyopia-correcting IOLs
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.
ASCRS 2025: EVO ICL in low to moderate myopia may rival LASIK
Eva Kim, MD, offers valuable insights into why EVO ICL is becoming a compelling alternative to traditional corneal procedures like LASIK.
Empowering optometrists to take hold of myopia management
April 28th 2025In honor of the Myopia Management Navigator’s 1-year anniversary, Dr Tucker shares clinical insights, practical tips, and business opportunities for optometrists looking to expand their scope and elevate patient care through evidence-based myopia management.
CRU 2025: What eye care providers took home that is current, relevant, and useful
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
CRU 2025: The latest and greatest in retina
Rachelle Lin, OD, MS, FAAO, and Quan Đông Nguyễn, MD, MSc, lectured on retinal updates at CRU 2025. The pair also covered the power of a low vision referral for patients with retinal disease.
CRU 2025: Managing myopia today to prevent vision loss tomorrow
Dr Rachelle Lin highlights the urgent need for early intervention in childhood myopia, discusses associated retinal and systemic risks, and emphasizes the long-term impact of axial length control in reducing serious ocular complications.